The subject of the invention is a solid dosage form containing zinc gluconate and inosine pranobex and adjuvants characterized in that zinc gluconate is in an amount of 3.11% to 4.51% by mass of the dosage form, inosine pranobex is in an amount of 71.43% by mass of the dosage form, sodium carboxymethyl starch (type A) is in the range from 5% to 14% by weight of the dosage form and sodium lauryl sulfate at a level from 0.7% to 1% by weight of the dosage form and the mannitol content is from 6% to 10.7% by weight of the dosage form, and method of its preparation and its applications.
